CREO MEDICAL GROUP PLC ORD GBP0.001 chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.15
Dividend & YieldN/A£ (N/A)
Beta 1.18
Market capitalization 83.5M
Operating cash flow -29.14M
ESG Scores unknown

Company description

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio2.46
Working Capital-0.53
Return On Equity-0.32
Debt To Equity0.08
Fixed Asset Ratio0.14
Fixed Interest Cover-324.06

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 95.83k 3.28M 1.69M 1.88M
Total Cashflows From Investing Activities -855.67k -806.51k -20.97M -7.84M
Net Borrowings 278.84k -187.31k 1.17M -2.21M
Total Cash From Financing Activities 30.99M 49.12M 1.33M 31.99M
Change To Operating Activities
Issuance Of Stock 32.44M 52.07M 159k 36.39M
Net Income -9.87M -15.91M -20.32M -24.59M
Change In Cash 20.6M 36.46M -35.96M -1.56M
Effect Of Exchange Rate -35k -35k -35k 303k
Total Cash From Operating Activities -9.53M -11.85M -16.28M -26.01M
Depreciation 326.58k 565.36k 1.31M 2.41M
Change To Account Receivables -342.84k -552.7k -394k -3.17M
Other Cashflows From Financing Activities -1.73M -2.77M -2.18M -2.18M
Change To Netincome 395.4k 1.11M 381k 284k
Capital Expenditures -722.26k -484.01k -485k -5.98M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax -11.72M -18.62M -23.46M -30.34M
Net Income -9.87M -15.91M -20.32M -24.59M
Selling General Administrative 11.96M 19.01M 27.57M 41.51M
Gross Profit 4.95k 4.04M 11.59M
Ebit -11.78M -18.88M -23.48M -29.87M
Operating Income -11.78M -18.88M -23.48M -29.87M
Interest Expense -11.16k -14.07k -71k -209k
Income Tax Expense -1.85M -2.7M -3.15M -5.74M
Total Revenue 13.47k 9.43M 25.16M
Cost Of Revenue 8.52k 5.39M 13.58M
Total Other Income ExpenseNet 58.4k 260k 22k -467k
Net Income From Continuing Ops -9.87M -15.91M -20.32M -24.59M
Net Income Applicable To Common Shares -9.87M -15.91M -20.32M -24.59M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 2.03M 5.6M 29.66M 27.29M
Total Stockholder Equity 47.71M 82.66M 62.81M 73.32M
Other Current Liabilities 95.72k 41.67k 5.56M 5.63M
Total Assets 49.75M 88.26M 92.46M 100.61M
Common Stock 120.5k 150.38k 158k 181k
Other Current Assets
Retained Earnings -34.94M -50.85M -71.17M -95.76M
Treasury Stock 16.7M 18.25M 18.55M 19.45M
Cash 44.59M 81.05M 45.09M 43.53M
Total Current Liabilities 1.64M 5.06M 18.03M 19.74M
Other Stockholder Equity 16.7M 18.25M 18.55M 19.45M
Property, Plant, and Equipment 906.26k 1.3M 3.38M 8.6M
Total Current Assets 48.51M 86.09M 59.47M 61.17M
Net Tangible Assets 47.41M 81.92M 34.77M 46.42M
Net Receivables 3.32M 4.08M 7.33M 8.76M
Accounts Payable 739.01k 923.32k 2.46M 3.54M


Insider Transactions

Here are the insider transactions of stock shares related to CREO MEDICAL GROUP PLC ORD GBP0.001:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Bradshaw (John)Exercise of Option at price 0.26 per share.D2022-08-1027k
Bradshaw (John)Exercise of Option at price 0.93 per share.D2022-08-1078.95k
Gulliford (Craig Jonathan)D2022-08-05246.19k
Hancock (Christopher Paul)D2022-08-05184.65k
Rees (Richard)D2022-08-05184.65k
Rees (Richard)Bought at price 0.94 per share.D2022-07-291.18k
Gulliford (Craig Jonathan)Bought at price 0.94 per share.D2022-07-291.18k
Hancock (Christopher Paul)Bought at price 0.94 per share.D2022-07-291.18k
Axa Investment Managers UK LtdD2022-06-27
Baillie Gifford International Choice FundD2022-06-27
Capital GroupD2022-06-27
Creo Medical Group Employee Benefit TrustD2022-06-27
Finance Wales Investments LtdD2022-06-27
Gulliford (Craig Jonathan)D2022-06-27
Hancock (Christopher Paul)D2022-06-27
Hargreave Hale LtdD2022-06-27
M&G Alternatives Investment Management, Ltd.D2022-06-27
Rees (Richard)D2022-06-27
Spicer (Charles Alexander Evan)D2022-06-27
Tellworth Investments LLPD2022-06-27
Woods (David)D2022-06-27
Rees (Richard)Bought at price 1.22 per share.D2022-05-2670k
Spicer (Charles Alexander Evan)Bought at price 1.22 per share.D2022-05-2615.44k
Hargreave Hale LtdD2022-05-161.84M
Axa Investment Managers UK LtdD2021-12-31
Baillie Gifford International Choice FundD2021-12-31
Capital GroupD2021-12-31
Creo Medical Group Employee Benefit TrustD2021-12-31
Finance Wales Investments LtdD2021-12-31
Gulliford (Craig Jonathan)D2021-12-31
Hancock (Christopher Paul)D2021-12-31
Hargreave Hale LtdD2021-12-31
Rees (Richard)D2021-12-31
Spicer (Charles Alexander Evan)D2021-12-31
Tellworth Investments LLPD2021-12-31
Woods (David)D2021-12-31
Spicer (Charles Alexander Evan)Bought at price 2.52 per share.D2021-09-079.66k
Hargreave Hale LtdD2021-09-071.18M
Capital GroupD2021-09-036.09M
Gulliford (Craig Jonathan)Bought at price 0.83 per share.D2021-07-261.5k
Rees (Richard)Bought at price 0.83 per share.D2021-07-261.5k
Hargreave Hale LtdD2021-02-171.54M
Axa Investment Managers UK LtdD2020-12-31
Axa Investment Managers UK LtdD2020-12-31
Baillie Gifford International Choice FundD2020-12-31
Baillie Gifford International Choice FundD2020-12-31
Capital GroupD2020-12-31
Capital GroupD2020-12-31
Creo Medical Group Employee Benefit TrustD2020-12-31
Creo Medical Group Employee Benefit TrustD2020-12-31
Fidelity InternationalD2020-12-31

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to CREO MEDICAL GROUP PLC ORD GBP0.001. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on CREO MEDICAL GROUP PLC ORD GBP0.001

Here is the result of two systematic investment strategies applied to CREO MEDICAL GROUP PLC ORD GBP0.001. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the equity curve of the two systematic investment strategies applied to CREO MEDICAL GROUP PLC ORD GBP0.001:

CREO MEDICAL GROUP PLC ORD GBP0.001 automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -9.43% on the backtest period.

Performance at glance

Performance

-9.43 %

Latent gain

-177.5 £

Invested capital

1882.5 £

Annualized return

-2.29 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on CREO MEDICAL GROUP PLC ORD GBP0.001

This is the result of two momentum investment strategies applied to CREO MEDICAL GROUP PLC ORD GBP0.001. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows all the entries opened by the momentum investment system on CREO MEDICAL GROUP PLC ORD GBP0.001:

CREO MEDICAL GROUP PLC ORD GBP0.001 momentum entries
  • The first momentum investment strategy would give 0.31% of return on CREO MEDICAL GROUP PLC ORD GBP0.001. That represents 9.01£ of latent gain with 2935.99£ of employed capital.
  • The second momentum investment strategy would give 0.47% of return on CREO MEDICAL GROUP PLC ORD GBP0.001. That represents 10.25£ of latent gain with 2159.75£ of employed capital.
Performance at glance (1Q Momentum)

Performance

0.31 %

Latent gain

9.01 £

Invested capital

2935.99 £

Annualized return

-1.69 %
Performance at glance (2Q Momentum)

Performance

0.47 %

Latent gain

10.25 £

Invested capital

2159.75 £

Annualized return

0.13 %

Momentum equity curve on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the equity curve of the two momentum strategies applied to CREO MEDICAL GROUP PLC ORD GBP0.001:

CREO MEDICAL GROUP PLC ORD GBP0.001 momentum equity

Note: the dividends potentially given by CREO MEDICAL GROUP PLC ORD GBP0.001 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the employed capital evolution of the two momentum strategies on CREO MEDICAL GROUP PLC ORD GBP0.001 since the beginning:

CREO MEDICAL GROUP PLC ORD GBP0.001

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on CREO MEDICAL GROUP PLC ORD GBP0.001

Buy the dip entry openings on CREO MEDICAL GROUP PLC ORD GBP0.001

CREO MEDICAL GROUP PLC ORD GBP0.001

The performance achieved by the robo-advisor on CREO MEDICAL GROUP PLC ORD GBP0.001 is -3.58%. That represents -23.0$ of latent gain with 643.0£ of employed capital. The following chart shows CREO MEDICAL GROUP PLC ORD GBP0.001 stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of CREO MEDICAL GROUP PLC ORD GBP0.001, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-3.58 %

Latent gain

-23.0 £

Invested capital

643.0 £

Annualized return

-1.69 %

Equity curve of the strategy applied to CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the result of the investment strategy applied to CREO MEDICAL GROUP PLC ORD GBP0.001:

CREO MEDICAL GROUP PLC ORD GBP0.001

Note: the dividends potentially given by CREO MEDICAL GROUP PLC ORD GBP0.001 are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the employed capital evolution since the beginning of the investment strategy on CREO MEDICAL GROUP PLC ORD GBP0.001:

CREO MEDICAL GROUP PLC ORD GBP0.001

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on CREO MEDICAL GROUP PLC ORD GBP0.001

In this section, I will compare the three previous investment strategies applied to CREO MEDICAL GROUP PLC ORD GBP0.001.

Equity curve comparison on CREO MEDICAL GROUP PLC ORD GBP0.001

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

CREO MEDICAL GROUP PLC ORD GBP0.001 investment strategy comparison

Employed capital comparison on CREO MEDICAL GROUP PLC ORD GBP0.001

CREO MEDICAL GROUP PLC ORD GBP0.001 investment comparison

Performance comparison on CREO MEDICAL GROUP PLC ORD GBP0.001

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -9.43% -177.5£ 1882.5£ -2.29%
Momentum 1 quarter 0.31% 9.01£ 2935.99£ 0.08%
Momentum 2 quarters 0.47% 10.25£ 2159.75£ 0.13%
Non-directional -3.58% -23.0£ 643.0£ -1.69%
Annualized return comparison

Automatic investment

-2.29 %

Momentum 1Q

0.13 %

Momentum 2Q

0.13 %

Non-directional

-1.69 %

Correlated stocks

Here are the most positively and negatively correlated stocks with CREO MEDICAL GROUP PLC ORD GBP0.001:

Positive correlations

Most correlated stocks this year

  • CREO MEDICAL GROUP PLC ORD GBP0.001

  • Most correlated stocks last 3 months

  • J.Jill Inc
  • CREO MEDICAL GROUP PLC ORD GBP0.001

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between CREO MEDICAL GROUP PLC ORD GBP0.001 and the other stocks. There may be false positives or some missing correlated stocks. If the price of CREO MEDICAL GROUP PLC ORD GBP0.001 does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name CREO MEDICAL GROUP PLC ORD GBP0.001
    Country United Kingdom
    City Chepstow
    Address Unit 2, Creo House
    Phone 44 1291 606005
    Website creomedical.com
    FullTime employees 316
    Industry Medical Devices
    Sector Healthcare
    Exchange XLON
    Ticker CREO.XLON
    Market www.londonstockexchange.com

    CREO MEDICAL GROUP PLC ORD GBP0.001 ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown